423 related articles for article (PubMed ID: 26369960)
1. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
2. Understanding the determinants of substrate specificity in IMP family metallo-β-lactamases: the importance of residue 262.
Pegg KM; Liu EM; George AC; LaCuran AE; Bethel CR; Bonomo RA; Oelschlaeger P
Protein Sci; 2014 Oct; 23(10):1451-60. PubMed ID: 25131397
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.
Horton LB; Shanker S; Mikulski R; Brown NG; Phillips KJ; Lykissa E; Venkataram Prasad BV; Palzkill T
Antimicrob Agents Chemother; 2012 Nov; 56(11):5667-77. PubMed ID: 22908171
[TBL] [Abstract][Full Text] [Related]
4. Impact of remote mutations on metallo-beta-lactamase substrate specificity: implications for the evolution of antibiotic resistance.
Oelschlaeger P; Mayo SL; Pleiss J
Protein Sci; 2005 Mar; 14(3):765-74. PubMed ID: 15722450
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1.
Brown NG; Horton LB; Huang W; Vongpunsawad S; Palzkill T
Antimicrob Agents Chemother; 2011 Dec; 55(12):5696-702. PubMed ID: 21896903
[TBL] [Abstract][Full Text] [Related]
6. Insight into stereochemistry of a new IMP allelic variant (IMP-55) metallo-β-lactamase identified in a clinical strain of Acinetobacter baumannii.
Shakibaie MR; Azizi O; Shahcheraghi F
Infect Genet Evol; 2017 Jul; 51():118-126. PubMed ID: 28336429
[TBL] [Abstract][Full Text] [Related]
7. Role of Residues W228 and Y233 in the Structure and Activity of Metallo-β-Lactamase GIM-1.
Skagseth S; Carlsen TJ; Bjerga GE; Spencer J; Samuelsen Ø; Leiros HK
Antimicrob Agents Chemother; 2016 Feb; 60(2):990-1002. PubMed ID: 26643332
[TBL] [Abstract][Full Text] [Related]
8. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
9. Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site.
Morán-Barrio J; Lisa MN; Larrieux N; Drusin SI; Viale AM; Moreno DM; Buschiazzo A; Vila AJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):6013-22. PubMed ID: 27458232
[TBL] [Abstract][Full Text] [Related]
10. E152A substitution drastically affects NDM-5 activity.
Kumar G; Issa B; Kar D; Biswal S; Ghosh AS
FEMS Microbiol Lett; 2017 Feb; 364(3):. PubMed ID: 28087620
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism.
Zhang H; Hao Q
FASEB J; 2011 Aug; 25(8):2574-82. PubMed ID: 21507902
[TBL] [Abstract][Full Text] [Related]
12. A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis.
Stojanoski V; Chow DC; Hu L; Sankaran B; Gilbert HF; Prasad BV; Palzkill T
J Biol Chem; 2015 Apr; 290(16):10382-94. PubMed ID: 25713062
[TBL] [Abstract][Full Text] [Related]
13. Role of Non-Active-Site Residue Trp-93 in the Function and Stability of New Delhi Metallo-β-Lactamase 1.
Khan AU; Rehman MT
Antimicrob Agents Chemother; 2016 Jan; 60(1):356-60. PubMed ID: 26525789
[TBL] [Abstract][Full Text] [Related]
14. Residues Distal to the Active Site Contribute to Enhanced Catalytic Activity of Variant and Hybrid β-Lactamases Derived from CTX-M-14 and CTX-M-15.
He D; Chiou J; Zeng Z; Liu L; Chen X; Zeng L; Chan EW; Liu JH; Chen S
Antimicrob Agents Chemother; 2015 Oct; 59(10):5976-83. PubMed ID: 26169409
[TBL] [Abstract][Full Text] [Related]
15. Multitarget selection of catalytic antibodies with β-lactamase activity using phage display.
Shahsavarian MA; Chaaya N; Costa N; Boquet D; Atkinson A; Offmann B; Kaveri SV; Lacroix-Desmazes S; Friboulet A; Avalle B; Padiolleau-Lefèvre S
FEBS J; 2017 Feb; 284(4):634-653. PubMed ID: 28075071
[TBL] [Abstract][Full Text] [Related]
16. Mutation S115T in IMP-Type Metallo-β-Lactamases Compensates for Decreased Expression Levels Caused by Mutation S119G.
Zhang CJ; Faheem M; Dang P; Morris MN; Kumar P; Oelschlaeger P
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31718049
[TBL] [Abstract][Full Text] [Related]
17. Potency of IMP-10 metallo-beta-lactamase in hydrolysing various antipseudomonal beta-lactams.
Zhao WH; Hu ZQ; Shimamura T
J Med Microbiol; 2008 Aug; 57(Pt 8):974-979. PubMed ID: 18628498
[TBL] [Abstract][Full Text] [Related]
18. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
[TBL] [Abstract][Full Text] [Related]
19. Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6.
Oelschlaeger P; Schmid RD; Pleiss J
Biochemistry; 2003 Aug; 42(30):8945-56. PubMed ID: 12885227
[TBL] [Abstract][Full Text] [Related]
20. Difference in the Inhibitory Effect of Thiol Compounds and Demetallation Rates from the Zn(II) Active Site of Metallo-β-lactamases (IMP-1 and IMP-6) Associated with a Single Amino Acid Substitution.
Yamaguchi Y; Kato K; Ichimaru Y; Uenosono Y; Tawara S; Ito R; Matsuse N; Wachino JI; Toma-Fukai S; Jin W; Arakawa Y; Otsuka M; Fujita M; Fukuishi N; Sugiura K; Imai M; Kurosaki H
ACS Infect Dis; 2023 Jan; 9(1):65-78. PubMed ID: 36519431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
